病毒性心肌炎采用黄芪注射液联合磷酸肌酸钠治疗临床效果观察

Clinical effect of astragalus injection combined with creatine phosphate sodium in the treatment of viral myocarditis

目的观察病毒性心肌炎采用黄芪注射液联合磷酸肌酸钠治疗临床效果。方法选取2017年7月至2018年7月本院收治病的毒性心肌炎患者80例,通过随机数字表法进行分组,分为观察组(n=40)和对照组(n=40)。对照组行常规治疗,观察组为常规的治疗方法上给予黄芪注射液联合磷酸肌酸钠治疗。对比两组的临床效果。结果观察组临床治疗效果和对照组的治疗效果比较分析,差异具有统计学意义(P<0.05)。结论病毒性心肌炎采用黄芪注射液联合磷酸肌酸钠治疗,临床效果显著,能对患者的各项指标优化改善,在临床上值得进一步推广。

Objective To observe the clinical effect of astragalus injection combined with creatine phosphate sodium in the treatment of viral myocarditis.Methods From July 2017 to July 2018,80 patients with viral myocarditis were divided into observation group(n=40)and control group(n=40).The control group was treated with routine therapy,the observation group was treated with astragalus injection combined with creatine phosphate sodium.The clinical effects of the two groups were compared.Results Compared with the control group,the clinical effect of the observation group was significantly worse than that of the control group,the difference between the two groups was statistically significant(P<0.05).Conclusion The treatment of viral myocarditis with astragalus injection combined with creatine phosphate sodium has remarkable clinical effect and can optimize and improve the indexes of the patients,it is worth further popularizing in clinic.